17:10 uur 06-11-2015

RWS koopt toonaangevend vertaalbedrijf voor levenswetenschappen

LONDON–(BUSINESS WIRE)– Corporate Translations Inc (CTi), wereldmarktleider in vertaaldiensten en linguïstische validatie binnen de levenswetenschappen, is overgenomen door RWS. RWS is een toonaangevende aanbieder van ondersteunende diensten op gebied van intellectueel eigendom. De overname past binnen de strategie van RWS, dat streeft naar organische groei door middel van selectieve overnames.

CTi is gevestigd in Connecticut en opgericht in 1990. Het bedrijf komt tegemoet aan de groeiende vraag naar kwalitatief hoogstaande vertaaldiensten binnen de levenswetenschappen. CTi is inmiddels erkend leider in het succesvol ten uitvoer brengen van complexe vertaalprojecten, vaak in opdracht van topondernemingen uit de farmacie en biotechnologie of uitvoerders van uitbesteed onderzoek. Aangezien klanten van CTi werken in sectoren die onder streng toezicht staan, hechten ze veel waarde aan kwalitatief hoogstaande vertalingen en respect voor deadlines. CTi is voor veel klanten de voorkeursleverancier en is diep doorgedrongen tot de blue chip-bedrijven uit de levenswetenschappen.


RWS Acquires Leading Life Sciences Translation Company

LONDON–(BUSINESS WIRE)– Corporate Translations Inc (CTi), the world’s leading life sciences translation and linguistic validation provider, has been acquired by RWS, the leading provider of intellectual property support services. The acquisition is in line with the strategy of complementing organic growth with selective acquisition.

CTi is based in Connecticut, USA and founded in 1990 to cater for the growing demand for high quality translation services in the life sciences sector. It is now a recognised leader in successfully managing complex translation projects on behalf of the world’s top pharmaceutical and biotech companies and their Clinical Research Organisation partners. As CTi’s customers operate in highly regulated and audited industries, they place a premium on high quality translations being delivered to specific deadlines. CTi enjoys a preferred supplier relationship with many of its customers, with extraordinary penetration of the blue chip life science community.

RWS already focuses on the life sciences sector, through its patent translation and filing solutions, and with its separate Medical Translation Division which includes the linguistic validation specialist PharmaQuest.

The scale of CTi, combined with the specialist RWS divisions will immediately transform the Group to a preeminent position in life sciences translations and linguistic validation and further enhance its competitive standing amongst the largest specialist translation companies in the world.

Andrew Brode, Chairman of RWS Holdings, commented:

“We are delighted to have acquired CTi, which greatly expands our exposure to the attractive and growing life sciences sector through a world leading language services provider in this field. With its focus on supporting clients in the delivery of their intellectual property pipelines, CTi is an excellent fit with RWS’ leading position in IP service provision.

“We look forward to building on CTi’s strong reputation and financial track record, particularly as RWS adds its own life science division and client base, and provides a platform from which it can achieve further expansion into the European life science support services sector.

About RWS:

RWS Group is a global leader in language services, employing over 600 staff worldwide. It is a leading provider of intellectual property support services and high level technical translation and localisation services for clients in the engineering, electronics, pharmaceutical and life sciences, chemical, legal and financial industries.

For further information please contact marketing@rws.com and visit: www.rws.com


Chris Rayner
+44 (0)1753480200

Check out our twitter: @NewsNovumpr